Tips For Avoiding Missed Injuries

In the last two posts, I’ve examined the phenomenon of “delayed diagnosis” or missed injury. I believe that there are only two fundamental reasons why this occurs:

  • Insufficient diagnostic technique – A good physical exam and/or specific diagnostic techniques were not performed. Or rarely, the injury cannot be readily detected by existing techniques and technology. The former is usually the real problem and may be an issue with either the physical exam completeness and/or technique, or judgment used to obtain the appropriate diagnostic test. Example 1: a penetrating injury to the back is missed because the patient is not logrolled to examine this area. Example 2: a spine fracture is missed in an elderly patient with a fall from standing because the back pain found on physical exam is evaluated only with conventional imaging of the spine, not CT.
  • Failure to recognize the injury – The injury was actually identified on a test but was not appreciated by the clinician. Example 1: the radiologist may not have appreciated and reported out a subtle anomaly in the cervical spine imaging. Example 2: you fail to check your patient’s lab tests and miss a sudden spike in serum amylase or lipase the day after your patient was kicked in the epigastrium by a horse.

So what can you do to avoid this potential problem? Here are some tips:

  • Admit that it can really happen to you. If the missed injury rate at your center is off the low end of the bell curve (< 5%), then you are either really good or really blind. You’d better take a close look at your performance improvement process because you may be fooling yourself.
  • Adopt a firm definition of “delayed diagnosis.” Basically, you need a time frame after which a new diagnosis is considered “delayed.” It should be a reasonable time interval after the patient has left the ED. If it’s too short an interval (e.g. once they leave the ED), your number will be unnecessarily high. If it’s too long (days and days later), then significant morbidity may occur that you don’t account for. Most centers have adopted 24, 36, or 48 hours after patient arrival.
  • Implement a tertiary survey process. This is a complete physical re-examination followed by a review of all diagnostic studies (lab and radiology) that have been performed. This exam needs to be dated and timed to ensure that it is performed within the time frame noted above. If a new finding is discovered on the tertiary survey, it is not considered a delayed diagnosis. If found after the survey (or after the pre-determined time interval), it is and must be entered into your performance improvement process.
  • Be paranoid. I hate the phrase, “maintain a high index of suspicion” because it’s meaningless. It’s like those stupid “start seeing motorcycles” bumper stickers. You can’t see what you can’t see. But you can be suspicious all the time, constantly looking for the inevitable clinical surprises of trauma care.

Are There Really More Missed Injuries After Hours?

In my last post, I wrote about the usual reasons for delayed diagnosis: insufficient diagnostic technique or insufficient recognition. What about the time of day? An interesting paper looked at the correlation between admission time and the rate of missed injuries.

The work was done at a large teaching hospital and Level I trauma center in Australia. A large number of patients were reviewed over an 11-year period. The study was complicated slightly by implementing a dedicated trauma unit in the middle of the study period, but the authors stratified their groups to account for this.

Results were stratified by time of admission: office hours, after-hours, and weekends. Missed injuries were defined as those found after the completion of the primary and secondary surveys. The overall statistical treatment appeared to be robust.

Here are the factoids:

  • A huge number of patients (53,000) were reviewed. This is a busy place!
  • There were 2519 missed injuries in 1262 patients (2.4%) [low!]
  • Missed injuries occurred during office hour admissions in 2.2%, after-hours in 2.6%, and on weekends 2.5% of the time
  • The increased incidence of delayed diagnosis in after-hours admits was marginally significant (p = 0.048)
  • Missed injuries appeared to have increased over time and were 1.34 times more likely at the end of the study period vs the beginning
  • Thoracic spine and abdominal injuries were most commonly missed

Bottom line: Hmm, time of day was not on my list of reasons for missing diagnoses. What gives? If you read the article closely, the trauma service at this hospital was staffed with a higher number of trainees after hours and on weekends than during office hours. It was also noted that incomplete physical examination was thought to be a factor in many of the delays. Most likely, both of my listed reasons were in play here. Inexperienced clinicians and insufficient examination are both major factors. And what about the increase in missed injuries over time? Midway through the study, the hospital implemented a dedicated trauma unit, and a tertiary exam became routine. This identified more injuries after the primary and secondary surveys were complete. 

In the next post, I’ll review strategies to decrease the incidence of missed injury.

Reference: Office hours vs after-hours: do presentation times affect the rate of missed injuries in trauma patients? Injury 2015, in press.

Missed Injury / Delayed Diagnosis

Missed injuries (or delayed diagnosis in polite conversation) are the bane of any trauma program. Trauma professionals want to know that they’ve identified all significant injuries in their patients so no future harm will occur due to them.

But what exactly is a missed injury? The definitions tend to vary a bit, which is why their incidence varies so widely in the literature (1 – 39%). The simplest way to describe one is any injury that is identified after a set amount of time. But what is a reasonable time frame? Some define it as the time spent in the emergency department (highest incidence). Others count any injury found after a predetermined period of time (typically 24-48 hours). Some use even longer time intervals, so they obviously look the best and have the lowest incidence.

And what are the factors that contribute to us “missing” these injuries? As you can imagine, there are quite a few, but they boil down to two major categories:

  • Inadequate diagnostic technique (physical exam and/or technology) – I can’t see it
  • Inadequate recognition – I didn’t think of it

A good physical exam with the focused use of appropriate imaging is paramount. Sure, you could use a shotgun approach and just scan everything. The problem is that CT scans have limitations, but we tend to forget that. So we believe that if we don’t see anything on scan, it must not exist. Wrong! The physical exam may pick up suspicious findings that tell the clinician that a specialized study is necessary to rule a potential injury out.

The failure to recognize that an injury is present can occur with everyone that “touches” the patient. The EMT or physician may not appreciate a subtle injury. The radiologist may miss a problem on the images they read. The surgeon might even fail to notice another injury separate from the one she is operating for. Obviously, experience plays a large part in this factor. Students will fail to appreciate a potential injury that a senior clinician will detect rapidly.

What to do about it? In my next post, I’ll review a paper that tries to correlate missed injuries with time of admission. And finally, I’ll discuss some strategies to try to help keep it from happening to you.

Trauma Patient Mortality In ALS vs BLS Prehospital Transport

There is a presumption that more education and attainment of more advanced skills lead to greater expertise in just about any field. The same argument holds true for prehospital provider training. Training to be an ALS provider (advanced EMT or paramedic) should add extra value in patient care over and above BLS training (emergency medical responder or EMT).

One way to measure that added value is by comparing trauma patient mortality across those levels of training. Paradoxically, many studies have shown either no benefit or an actual increase in mortality. How does this make sense? Some have speculated that the advanced training leads providers to “stay and play” and use the skills that they have learned. Other possibilities include study design issues (low subject numbers) or failure to consider some unknown variables that impact mortality.

A paper published just this month from Hennepin County Medical Center in Minneapolis examined this phenomenon more closely to determine whether this effect is real or whether other factors are involved. They performed a retrospective study of a nationwide database of prehospital ground transports, selecting records that involved only injured patients. Only patients with documented ALS or BLS providers who were transported to Level I or II trauma centers were included. The ratio of ALS to BLS transports was about 15:1, so propensity matching was performed to create equal groups for comparison.

Here are the factoids:

  • A total of 1,154 matched pairs were available for study,
  • Overall, mortality was significantly lower in the patient group transported by ALS providers
  • Mortality was also significantly lower in older patients (age > 50) and those with mechanisms other than falls
  • There was no statistical difference in patients with falls or in those with prolonged transport times

The authors concluded that more advanced prehospital training is associated with survival. They recognized that there are many factors in the care process that are not captured in the usual databases that may have an impact on survival.

Bottom line: This study was nicely designed and well-executed. It has the largest subject pool of any of the papers published on this topic. It shows that survival is higher when ALS providers transport the patient. But keep in mind that it does not show causality. We don’t know exactly why this is true. It could certainly be the advanced education, but there is still the possibility of other variables that we either haven’t thought of or are not captured in the available databases. But until we know better, we should encourage all EMS providers to up their game, and skill level! 

Reference: Emergency medical services level of training is associated with mortality in trauma patients: A combined prehospital and in-hospital database analysis. Journal of Trauma and Acute Care Surgery ():10.1097/TA.0000000000004540, January 9, 2025.

Direct Oral Anticoagulant (DOAC) Reversal: Part 3

In my last two posts, I reviewed some older papers on the efficacy of Andexxa (andexanet alfa) for the reversal of Factor Xa inhibitor anticoagulants. Those results were not very impressive, especially considering the high cost of this drug.

In 2021, an article was published (reference 1) that performed a systematic review of the literature from 2017 to 2020. It concluded that “available evidence does not unequivocally support the clinical effectiveness of andexanet alfa or prothrombin complex concentrate to reverse factor Xa inhibitor-associated acute major bleeding.” This is a very roundabout way of saying that it didn’t really work. The authors also set out to perform a meta-analysis but could not do so, given the data’s low quality.

However, 2024 was a banner year for systematic reviews of this type of study! Four of them with meta-analyses were published comparing andexanet alfa (AA) with 4-factor prothrombin complex concentrate (PCC). And to keep it confusing, the conclusions were highly variable. Results were evaluated based on successful anticoagulation (hemostatic efficacy), mortality, and thrombotic complications. I also closely reviewed the conflict of interest information if any of the authors had any relationship to AstraZeneca, which owns both AA and the anticoagulant it reverses (Andexxa).

The results were very interesting. Here is a table that condenses the key points.

Reference # Hem. Effic. Mort. Thrombosis Conflict
2 AA better No diff. AA higher No
3 —– No diff. AA higher No
4 No diff. No diff. AA higher. Yes
5 AA better AA lower No diff. Yes

Many of the same original studies were analyzed in more than one of these reviews. And unfortunately, the results and confidence intervals were mysteriously a bit different in each review.

I specifically highlighted the efficacy and thrombosis results in red in Paper #4 because the authors stated that the efficacy of AA was qualitatively higher and the thrombotic complications the same. But their analysis in the body of the paper suggested otherwise. These were qualitative trends and are overhyped in the section most people read in PubMed, the abstract. My red text reflects how the abstract should have read. This is very misleading.

I also find it interesting that paper #5, with five of the nine authors either employed by or speaking for the company, was the only one that found the AA mortality lower and the thrombotic events no different than PCC. I believe this represents significant bias, and I find it hard to believe that the authors would be allowed to publish a negative or even neutral study about a drug that their company owns.

Bottom line: Who to believe?

Restoring clotting: Most of these studies indicated that andexanet alfa may restore hemostasis more effectively.

Preventing death: This drug doesn’t appear to reduce mortality, which is the outcome we are most interested in when treating these patients.

Thrombotic complications. These do seem to be more common when AA is given.

And even after ten years, cost is still a major consideration. The average cost of a course of treatment in 2023 was $26,787 (ref 6). Can we justify such an expense if it doesn’t seem to save lives? This is a decision that you and your hospital administration will have to work out. At least until much, much better data comes along.

References:

  1. Andexanet Alfa or Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Acute Major Bleeding: A Systematic Review and Meta-Analysis. Crit Care Med. 2021 Oct 1;49(10):e1025-e1036. doi: 10.1097/CCM.0000000000005059. PMID: 33967205.
  2. Efficacy and Safety of Andexanet Alfa Versus Four Factor Prothrombin Complex Concentrate for Emergent Reversal of Factor Xa Inhibitor Associated Intracranial Hemorrhage: A Systematic Review and Meta-Analysis. Neurocrit Care. 2024 Oct 8. doi: 10.1007/s12028-024-02130-y. Epub ahead of print. PMID: 39379749.
  3. Andexanet alpha versus four-factor prothrombin complex concentrate in DOACs anticoagulation reversal: an updated systematic review and meta-analysis. Crit Care. 2024 Jul 5;28(1):221. doi: 10.1186/s13054-024-05014-x. PMID: 38970010; PMCID: PMC11225147.
  4. Andexanet Alfa versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Factor Xa (FXa) Inhibitor-Associated Intracranial Hemorrhage: A Systematic Review of Retrospective Studies. J Clin Med. 2024 May 24;13(11):3077. doi: 10.3390/jcm13113077. PMID: 38892788; PMCID: PMC11173120.
  5. Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis. Pharmacotherapy. 2024 May;44(5):394-408. doi: 10.1002/phar.2925. Epub 2024 May 9. PMID: 38721837.
  6. Cost information link

Home of the Trauma Professional's Blog

Do you want to get a daily email every time there’s a new post? See what I’m up to.

Click here to get details and subscribe!

[accua-form fid=”1″]

[mc4wp_form id=”2023″]